查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828143

2025年血脂檢查全球市場報告

Lipid Panel Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，血脂檢查市場規模強勁成長，從2024年的108.8億美元增加至2025年的116.1億美元，複合年成長率為6.7%。預測期內的成長可歸因於心血管疾病盛行率的上升、預防保健意識的增強、政府對心血管健康的舉措、生活方式和飲食習慣的改變、人口老齡化以及慢性疾病。

預計未來幾年血脂檢查市場將強勁成長，到2029年將達到162.7億美元，複合年成長率為8.8%。預測期內的成長可歸因於基因檢測和個人化醫療的興起、對早期檢測和預防的重視、家用檢測套組的擴展、對基於價值的護理模式的重視以及高危險群篩檢的增加。預測期內的主要趨勢包括就地檢驗、與電子健康記錄的整合、基因血脂檢測、家用檢測套組、與遠端醫療的整合以及血脂管理的教育舉措。

血脂檢查血液測試，用於測量血液中各種脂質（或脂肪）的水平。此測試通常用於評估心血管疾病的風險。

與血脂檢查相關的主要產品和服務包括儀器、套件和服務。分析儀等設備用於進行血脂檢查。血脂檢查的處方模式多種多樣，包括處方箋和商店(OTC) 檢測。血脂檢查適用於多種疾病，包括高血脂症、高三酸甘油脂血症、遺傳性高膽固醇症、低脂蛋白血症、丹吉爾氏症和動脈粥狀硬化。血脂檢查產品和服務的最終使用者包括醫院、專科診所、醫生辦公室、病理實驗室、診斷診所、門診手術中心、參考實驗室和學術研究機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供血脂檢查市場統計數據，例如全球市場規模、區域佔有率、血脂檢查血脂檢查市場佔有率的競爭對手、詳細的脂質檢測細分市場、市場趨勢和機遇，以及您在血脂檢查檢測行業血脂檢查。本血脂檢查市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年8.8%的預測成長率，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這可能會直接影響美國，因為美國對來自瑞士和韓國等主要地區的酶促膽固醇試劑和自動化脂蛋白分餾模組徵收關稅，從而導致心血管風險評估的延遲和預防性篩檢成本的增加。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

心血管和糖尿病發病率的預期上升預計將推動血脂檢查市場的發展。心血管疾病是一組影響心臟和血管的疾病，而糖尿病是一種影響胰島素分泌並導致血糖值紊亂，這兩者共同導致了血脂檢查的需求。這種診斷工具對於識別有心血管疾病風險或心血管疾病的個體至關重要。此外，它還有助於監測治療效果，使醫療保健提供者能夠調整治療計劃以達到目標血脂水平並降低進一步患病的風險。根據世界衛生組織 2023 年 9 月的數據，死於心血管疾病的人數為 1,790 萬人。此外，美國疾病管制與預防中心 (CDC) 發布的 2022 年全國糖尿病統計報告指出，美國糖尿病患者數量增加，達 3,730 萬人。因此，心血管和糖尿病盛行率的上升預計將推動血脂檢查市場的發展。

肥胖率的上升是推動血脂檢查市場發展的關鍵因素。肥胖的特徵是體內脂肪堆積過多，會對健康造成不良影響，需要透過血脂檢查進行有效評估和管理。這種診斷工具在識別血脂異常症、指導生活方式介入、制定個人化治療方案、監測治療效果、早期發現METABOLIC INC.症候群以及評估心血管疾病風險方面發揮關鍵作用。根據英國政府數位服務局 2023 年 5 月的數據，2021 年至 2022 年間，英格蘭 18 歲及以上人口中肥胖率為 25.9%，預計這一數字將成長 25.2%。因此，肥胖率的上升正在推動血脂檢查市場的發展。

血脂檢查市場的關鍵趨勢是領導企業對產品創新的重視。這些公司致力於開發創新產品以維持其市場地位。例如，2022年10月，美國生技公司波士頓心臟診斷公司（Boston Heart Diagnostics）推出了LipoMap，這是一套包含33項脂質、脂蛋白和載脂蛋白檢測的檢測方案。 LipoMap提供了市面上最全面的脂質代謝檢測評估，並能識別與心血管疾病相關的可治療和可逆的脂質異常。這項技術創新使治療和後續檢測的個人化成為可能。

血脂檢查市場的主要企業正策略性地專注於智慧型手機診斷技術等先進解決方案，以推動市場收益成長。基於智慧型手機的診斷技術利用智慧型手機的功能，提供便利、易用且通常照護現場的解決方案。例如，2022年1月，英國數位健康平台PocDoc推出了一款基於智慧型手機的心血管疾病血脂檢查。 PocDoc應用程式可讓使用者在家中方便地進行精準、定量的血液膽固醇檢測，測量五個對心臟健康至關重要的指標。

2022年10月，美國醫療保健公司CVS Health Corporation與ixlayer Inc.建立夥伴關係。這家美國公司提供脂質檢測套組，有助於透過家庭檢測擴大醫療保健的可近性。

血脂檢查市場的主要企業包括雅培實驗室、貝克曼庫爾特公司、羅氏公司、朗道實驗室有限公司、賽默飛世爾科技公司、PTS Diagnostics、Quest Diagnostics Incorporated、Alere Inc.、EuroMedix International、波士頓心臟診斷公司、Eurofins Scientific SE、Spark Diagnosnostics Pvernos、Evernosu. Biomedical Corporation、Bio-Rad Laboratories Inc.、丹納赫公司、DiaSorin SpA、EKF Diagnostics Holdings plc、Grifols SA、Hologic Inc.、Luminex Corporation、Meridian Bioscience Inc. 和 Ortho Clinical Diagnostics LLC。

2024年，北美是血脂檢查市場最大的地區。預計在預測期內，亞太地區將成為全球血脂檢查市場成長最快的地區。血脂檢查市場報告涵蓋亞太地區、西歐、東歐、北美、南美以及中東和非洲。

血脂檢查市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙

血脂檢查市場由提供高膽固醇檢測和脂蛋白分析的營業單位所獲得的收益所構成。市場價值包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。血脂檢查市場還包括用於提供檢測服務的膽固醇檢測套組、血脂譜分析儀和膽固醇自測試劑檢測套組的銷售額。該市場中的商品價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球血脂檢查：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球血脂檢查市場：成長率分析
  • 全球血脂檢查市場表現：規模與成長，2019-2024
  • 全球血脂檢查市場預測：規模與成長，2024-2029 年，2034 年
  • 全球血脂檢查：總目標市場（TAM）

第6章 市場細分

  • 全球血脂檢查市場：依產品/服務、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 套件
  • 服務
  • 全球血脂檢查市場（按配方、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 處方箋測試
  • OTC測試
  • 全球血脂檢查市場的應用、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 高血脂症
  • 高三酸甘油脂血症
  • 遺傳性高膽固醇症
  • 低脂蛋白血症
  • 丹吉爾病
  • 動脈硬化
  • 其他用途
  • 全球血脂檢查市場（按最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所和醫生辦公室
  • 病理實驗室
  • 診斷診所
  • 門診手術中心
  • 參考實驗室
  • 學術研究機構
  • 其他最終用戶
  • 全球血脂檢查市場：按設備類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 自動分析儀
  • 就地檢驗設備
  • 光強度
  • 全球血脂檢查市場：按套件類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 膽固醇檢測套組
  • HDL 和 LDL套件
  • 三酸甘油酯檢測套組
  • 全球血脂檢查市場：按服務類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 實驗室測試服務
  • 診斷服務
  • 健康檢查服務

第7章 區域和國家分析

  • 全球血脂檢查市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球血脂檢查市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 血脂檢查市場：競爭格局
  • 血脂檢查市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • PTS Diagnostics
  • Quest Diagnostics Incorporated
  • Alere Inc.
  • EuroMedix International
  • Boston Heart Diagnostics Corporation
  • Eurofins Scientific SE
  • Spark Diagnostics Pvt Ltd.
  • Everlywell Inc.
  • Horiba ABX SAS
  • Siemens Healthcare GmbH
  • Nova Biomedical Corporation
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • EKF Diagnostics Holdings plc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年血脂檢查市場：提供新機會的國家
  • 2029 年血脂檢查市場：細分市場帶來新機會
  • 2029 年血脂檢查市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24270u

Lipid panel testing refers to a blood test that measures the levels of various lipids or fats in the blood. This test is commonly used to assess an individual's risk of developing cardiovascular disease.

The main products and services related to lipid panel testing include devices, kits, and services. Devices, such as analyzer machines, are the equipment used to perform lipid panel testing. The various prescription modes for lipid panel testing include prescription-based testing and over-the-counter (OTC) based testing. Lipid panel testing is applied in various conditions such as hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypo-lipoproteinamia, Tangier disease, atherosclerosis, and others. The diverse end users of lipid panel testing products and services encompass hospitals, specialty clinics and physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The lipid panel testing market research report is one of a series of new reports from The Business Research Company that provides lipid panel testing market statistics, including lipid panel testing industry global market size, regional shares, competitors with a lipid panel testing market share, detailed lipid panel testing market segments, market trends and opportunities, and any further data you may need to thrive in the lipid panel testing industry. This lipid panel testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lipid panel testing market size has grown strongly in recent years. It will grow from $10.88 billion in 2024 to $11.61 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increased incidence of cardiovascular diseases, growth in awareness of preventive healthcare, government initiatives for cardiovascular health, lifestyle changes and dietary patterns, aging population and chronic diseases.

The lipid panel testing market size is expected to see strong growth in the next few years. It will grow to $16.27 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to genetic testing and personalized medicine, focus on early detection and prevention, expansion of home testing kits, focus on value-based care models, increased screening in high-risk populations. Major trends in the forecast period include point-of-care testing, integration with electronic health records, genetic lipid testing, home-based testing kits, telemedicine integration, educational initiatives for lipid management.

The forecast of 8.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on enzymatic cholesterol reagents and automated lipoprotein fractionation modules, sourced from key regions such as Switzerland and South Korea, which could lead to slower cardiovascular risk assessments and higher costs for preventive health screenings.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in cardiovascular and diabetic diseases is poised to drive the growth of the lipid panel testing market. Cardiovascular disease, a cluster of conditions affecting the heart and blood vessels, along with diabetes, a metabolic disorder impacting insulin production and leading to elevated blood sugar levels, collectively contribute to the demand for lipid panel testing. This diagnostic tool is crucial for identifying individuals at risk of developing cardiovascular diseases or those already affected. Additionally, it aids in monitoring treatment effectiveness, enabling healthcare providers to adjust treatment plans to attain target lipid levels and mitigate the risk of further ailments. According to the World Health Organization's data in September 2023, there were 17.9 million deaths attributed to cardiovascular diseases. Furthermore, the Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report in 2022 indicated an increase in diabetes cases in the US, reaching 37.3 million. Consequently, the escalating prevalence of cardiovascular and diabetic diseases is expected to propel the lipid panel testing market forward.

The rising prevalence of obesity is identified as a significant factor boosting the lipid panel testing market. Obesity, characterized by excessive body fat accumulation with adverse health effects, necessitates effective assessment and management through lipid panel testing. This diagnostic tool plays a crucial role in identifying dyslipidemia, guiding lifestyle interventions, devising personalized treatment plans, monitoring treatment efficacy, detecting metabolic syndrome early, and assessing cardiovascular disease risk. According to the Government Digital Service in May 2023, it was projected that 25.9% of individuals aged 18 and older in England were obese in 2021-2022, reflecting a 25.2% increase. Thus, the growing prevalence of obesity is a driving force behind the lipid panel testing market.

A key trend in the lipid panel testing market is the emphasis on product innovations by major companies. These companies are dedicated to developing innovative products to maintain their market position. For instance, in October 2022, Boston Heart Diagnostics, a US-based biotechnology company, introduced LipoMap-a panel comprising 33 lipid, lipoprotein, and apolipoprotein tests. LipoMap offers one of the most comprehensive assessments of lipid metabolism commercially available, uncovering treatable and reversible lipid abnormalities associated with cardiovascular disease. This innovation allows for greater personalization of treatment and follow-up testing.

Major companies operating in the lipid panel testing market are strategically focusing on advanced solutions, such as smartphone-based diagnostic technologies, to drive market revenues. Smartphone-based diagnostic technologies leverage smartphone capabilities to provide convenient, accessible, and often point-of-care diagnostic solutions. For instance, in January 2022, PocDoc, a UK-based digital health platform, launched a smartphone-based lipid panel test for cardiovascular disease. The PocDoc app enables users to perform a precise, quantitative blood test for cholesterol levels conveniently at home, measuring five essential heart-healthy markers.

In October 2022, CVS Health Corporation, a US-based healthcare company, entered into a partnership with ixlayer Inc. This collaboration aims to enhance global health by making health testing more accessible, affordable, and straightforward through advanced at-home testing kits and digital platforms. ixlayer Inc., a US-based company, provides lipid testing kits, contributing to the expansion of healthcare accessibility through at-home testing.

Major companies operating in the lipid panel testing market include Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., EuroMedix International, Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Grifols S.A., Hologic Inc., Luminex Corporation, Meridian Bioscience Inc., Ortho Clinical Diagnostics LLC

North America was the largest region in the lipid panel testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lipid panel testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lipid panel testing market consists of revenues earned by entities by providing high cholesterol testing and lipoprotein analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The lipid panel testing market also includes sales of cholesterol test kit, lipid profile analyzer, and cholesterol self-test kit which are used in providing testing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lipid Panel Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lipid panel testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lipid panel testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lipid panel testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Services: Devices; Kits; Services
  • 2) By Prescription Mode: Prescription-Based Testing; OTC-Based Testing
  • 3) By Application: Hyperlipidemia; Hypertriglyceridemia; Familial Hypercholesterolemia; Hypo-Lipoproteinemia; Tangier Disease; Atherosclerosis; Other Applications
  • 4) By End User: Hospital; Specialty Clinics And Physician Offices; Pathology Laboratories; Diagnostic Clinics; Ambulatory Surgical Centers; Reference Laboratories; Academic And Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Devices: Automated Analyzers; Point-Of-Care Testing Devices; Spectrophotometers
  • 2) By Kits: Test Kits For Cholesterol; HDL And LDL Kits; Triglyceride Test Kits
  • 3) By Services: Laboratory Testing Services; Diagnostic Services; Health Screening Services
  • Companies Mentioned: Abbott Laboratories; Beckman Coulter Inc.; F. Hoffmann-La Roche Ltd.; Randox Laboratories Ltd.; Thermo Fisher Scientific Inc.; PTS Diagnostics; Quest Diagnostics Incorporated; Alere Inc.; EuroMedix International; Boston Heart Diagnostics Corporation; Eurofins Scientific SE; Spark Diagnostics Pvt Ltd.; Everlywell Inc.; Horiba ABX SAS; Siemens Healthcare GmbH; Nova Biomedical Corporation; Bio-Rad Laboratories Inc.; Danaher Corporation; DiaSorin S.p.A.; EKF Diagnostics Holdings plc; Grifols S.A.; Hologic Inc.; Luminex Corporation; Meridian Bioscience Inc.; Ortho Clinical Diagnostics LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lipid Panel Testing Market Characteristics

3. Lipid Panel Testing Market Trends And Strategies

4. Lipid Panel Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Lipid Panel Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Lipid Panel Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Lipid Panel Testing Market Growth Rate Analysis
  • 5.4. Global Lipid Panel Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Lipid Panel Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Lipid Panel Testing Total Addressable Market (TAM)

6. Lipid Panel Testing Market Segmentation

  • 6.1. Global Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Devices
  • Kits
  • Services
  • 6.2. Global Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prescription-Based Testing
  • OTC-Based Testing
  • 6.3. Global Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Familial Hypercholesterolemia
  • Hypo-Lipoproteinamia
  • Tangier Disease
  • Atherosclerosis
  • Other Applications
  • 6.4. Global Lipid Panel Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Specialty Clinics And Physician Offices
  • Pathology Laboratories
  • Diagnostic Clinics
  • Ambulatory Surgical Centers
  • Reference Laboratories
  • Academic And Research Institutes
  • Other End-Users
  • 6.5. Global Lipid Panel Testing Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Analyzers
  • Point-Of-Care Testing Devices
  • Spectrophotometers
  • 6.6. Global Lipid Panel Testing Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Kits For Cholesterol
  • HDL And LDL Kits
  • Triglyceride Test Kits
  • 6.7. Global Lipid Panel Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing Services
  • Diagnostic Services
  • Health Screening Services

7. Lipid Panel Testing Market Regional And Country Analysis

  • 7.1. Global Lipid Panel Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Lipid Panel Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lipid Panel Testing Market

  • 8.1. Asia-Pacific Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lipid Panel Testing Market

  • 9.1. China Lipid Panel Testing Market Overview
  • 9.2. China Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lipid Panel Testing Market

  • 10.1. India Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lipid Panel Testing Market

  • 11.1. Japan Lipid Panel Testing Market Overview
  • 11.2. Japan Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lipid Panel Testing Market

  • 12.1. Australia Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lipid Panel Testing Market

  • 13.1. Indonesia Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lipid Panel Testing Market

  • 14.1. South Korea Lipid Panel Testing Market Overview
  • 14.2. South Korea Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lipid Panel Testing Market

  • 15.1. Western Europe Lipid Panel Testing Market Overview
  • 15.2. Western Europe Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lipid Panel Testing Market

  • 16.1. UK Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lipid Panel Testing Market

  • 17.1. Germany Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lipid Panel Testing Market

  • 18.1. France Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lipid Panel Testing Market

  • 19.1. Italy Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lipid Panel Testing Market

  • 20.1. Spain Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lipid Panel Testing Market

  • 21.1. Eastern Europe Lipid Panel Testing Market Overview
  • 21.2. Eastern Europe Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lipid Panel Testing Market

  • 22.1. Russia Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lipid Panel Testing Market

  • 23.1. North America Lipid Panel Testing Market Overview
  • 23.2. North America Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lipid Panel Testing Market

  • 24.1. USA Lipid Panel Testing Market Overview
  • 24.2. USA Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lipid Panel Testing Market

  • 25.1. Canada Lipid Panel Testing Market Overview
  • 25.2. Canada Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lipid Panel Testing Market

  • 26.1. South America Lipid Panel Testing Market Overview
  • 26.2. South America Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lipid Panel Testing Market

  • 27.1. Brazil Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lipid Panel Testing Market

  • 28.1. Middle East Lipid Panel Testing Market Overview
  • 28.2. Middle East Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lipid Panel Testing Market

  • 29.1. Africa Lipid Panel Testing Market Overview
  • 29.2. Africa Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lipid Panel Testing Market Competitive Landscape And Company Profiles

  • 30.1. Lipid Panel Testing Market Competitive Landscape
  • 30.2. Lipid Panel Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Lipid Panel Testing Market Other Major And Innovative Companies

  • 31.1. PTS Diagnostics
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Alere Inc.
  • 31.4. EuroMedix International
  • 31.5. Boston Heart Diagnostics Corporation
  • 31.6. Eurofins Scientific SE
  • 31.7. Spark Diagnostics Pvt Ltd.
  • 31.8. Everlywell Inc.
  • 31.9. Horiba ABX SAS
  • 31.10. Siemens Healthcare GmbH
  • 31.11. Nova Biomedical Corporation
  • 31.12. Bio-Rad Laboratories Inc.
  • 31.13. Danaher Corporation
  • 31.14. DiaSorin S.p.A.
  • 31.15. EKF Diagnostics Holdings plc

32. Global Lipid Panel Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lipid Panel Testing Market

34. Recent Developments In The Lipid Panel Testing Market

35. Lipid Panel Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Lipid Panel Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Lipid Panel Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Lipid Panel Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer